Redshift Bioanalytics Inc.

Boxborough, MA

UEI
UJ1TNDNGLFW7
CAGE
9CEB8
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
80 Central St, Boxborough, MA 01719, USA
Website
redshiftbio.com
Founded
2005
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Redshift Bioanalytics Inc.'s 4 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Annual service contract for AQS3/apollo Contract · 75N93025P00126 National Institute of Allergy and Infectious Diseases $26,250
Aurora MMS system, software and installation (ambis #2228865) Contract · 75N93024P00819 National Institute of Allergy and Infectious Diseases $139,900
AQS3/apollo service contract annual warranty and 2 PM visits Contract · 75N93024P00064 National Institute of Allergy and Infectious Diseases $0
AQS3 MMS system and accompanying components from redshift bioanalytics INC. (ambis 2135523) Contract · 75N93022P01251 National Institute of Allergy and Infectious Diseases $245,000

About Redshift Bioanalytics Inc.

Redshift Bioanalytics Inc. is a for-profit corporate entity registered in SAM.gov, specializing in the manufacture and sale of advanced bioanalytical instruments and related services. The company appears to be a sophisticated technology provider focused on precision scientific equipment for research and medical applications, with a primary operational base in Hamilton, Montana. Their business model centers on developing and maintaining high-end scientific instrumentation, particularly in the fields of protein structure analysis, data acquisition systems, and biomedical research technologies.

The company has exclusively secured federal contract awards from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), between 2022 and 2024. These awards consistently involve the procurement and maintenance of specialized scientific instruments, including the AQS3/APOLLO systems, Aurora MMS system, and Microfluidic Modulation Spectroscopy units. The contract awards range from $26,250 to $245,000, and are structured as firm-fixed-price purchase orders. Each contract has been awarded on a non-set-aside basis, indicating Redshift Bioanalytics competes openly for federal contracts. The contracts primarily support vaccine development, bacterial metabolism research, and high-throughput protein structure analysis, with services encompassing system procurement, software installation, maintenance, technical support, and on-site and remote repair services. All contracts have been with civilian agencies and do not involve defense-specific work.

Quick answers

What is Redshift Bioanalytics Inc.'s UEI?

Redshift Bioanalytics Inc.'s Unique Entity ID (UEI) in SAM.gov is UJ1TNDNGLFW7.

What is Redshift Bioanalytics Inc.'s CAGE code?

Redshift Bioanalytics Inc.'s CAGE code is 9CEB8.

What is Redshift Bioanalytics Inc.'s primary NAICS code?

Redshift Bioanalytics Inc.'s primary NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).

Where is Redshift Bioanalytics Inc. located?

Redshift Bioanalytics Inc.'s physical address in SAM.gov is 80 Central St, Boxborough, MA 01719, USA.

Is Redshift Bioanalytics Inc. registered in SAM.gov?

Yes. Redshift Bioanalytics Inc.'s SAM.gov registration is active through April 6, 2027.

What is Redshift Bioanalytics Inc.'s most recent federal award?

Redshift Bioanalytics Inc.'s most recent federal contract award is Annual service contract for AQS3/apollo (75N93025P00126), from National Institute of Allergy and Infectious Diseases, on December 6, 2024.

On GovTribe

See Redshift Bioanalytics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors